Antitumor bifunctional dinuclear PtII complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions

[1]  V. Brabec,et al.  Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro. , 2010, Chemical research in toxicology.

[2]  N. Farrell,et al.  Excursions in polynuclear platinum DNA binding. , 2010, Chemical communications.

[3]  M. Vorlíčková,et al.  Arrangements of human telomere DNA quadruplex in physiologically relevant K+ solutions , 2009, Nucleic acids research.

[4]  N. Sugimoto,et al.  Stabilization of three-way junctions of DNA under molecular crowding conditions. , 2009, Journal of the American Chemical Society.

[5]  M. Vorlíčková,et al.  Quadruplex-forming properties of FRAXA (CGG) repeats interrupted by (AGG) triplets. , 2009, Biochimie.

[6]  V. Brabec,et al.  Biochemical Studies of the Thermal Effects on DNA Modifications by the Antitumor Cisplatin and Their Repair , 2007, Chembiochem : a European journal of chemical biology.

[7]  L. Kèlland,et al.  The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.

[8]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[9]  Allen P. Minton,et al.  Cell biology: Join the crowd , 2003, Nature.

[10]  V. Brabec,et al.  DNA Interstrand Cross-links of the Novel Antitumor Trinuclear Platinum Complex BBR3464 , 2002, The Journal of Biological Chemistry.

[11]  V. Brabec,et al.  A comparison of DNA binding profiles of dinuclear platinum compounds with polyamine linkers and the trinuclear platinum phase II clinical agent BBR3464 , 2002, JBIC Journal of Biological Inorganic Chemistry.

[12]  R. Ellis.  Macromolecular crowding : obvious but underappreciated , 2022 .

[13]  C. Gaillard,et al.  Association of double-stranded DNA fragments into multistranded DNA structures. , 1999, Biopolymers.

[14]  V. Brabec,et al.  Sequence-dependent conformational changes in DNA induced by polynuclear platinum complexes. , 1999, Journal of inorganic biochemistry.

[15]  V. Brabec,et al.  Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking. , 1999, Biochemistry.

[16]  V. Brabec,et al.  DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent. , 1999, Biochemistry.

[17]  L. Matsumoto,et al.  Biological effects of a bifunctional DNA crosslinker. I. Generation of triradial and quadriradial chromosomes. , 1999, Mutation research.

[18]  N. Farrell,et al.  Selective Platination of Biologically Relevant Polyamines. Linear Coordinating Spermidine and Spermine as Amplifying Linkers in Dinuclear Platinum Complexes , 1997 .

[19]  P. Cook,et al.  The structure of 4-way DNA junctions: specific binding of bis-intercalators with rigid linkers. , 1996, Nucleic acids research.

[20]  V. Brabec,et al.  DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Minton,et al.  Macromolecular crowding: biochemical, biophysical, and physiological consequences. , 1993, Annual review of biophysics and biomolecular structure.

[22]  G. Lowe,et al.  Bisintercalators of DNA with a rigid linker in an extended configuration. , 1992, Biochemistry.

[23]  A. Rahmouni,et al.  Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Farrell,et al.  Cytotoxicity and antitumor activity of bis(platinum) complexes. A novel class of platinum complexes active in cell lines resistant to both cisplatin and 1,2-diaminocyclohexane complexes. , 1990, Journal of medicinal chemistry.

[25]  M. Leng,et al.  Sodium cyanide: a chemical probe of the conformation of DNA modified by the antitumor drug cis-diamminedichloroplatinum(II) , 1990 .

[26]  John D. Roberts,et al.  Interaction of novel bis(platinum) complexes with DNA. , 1989, Nucleic acids research.

[27]  S. Lippard,et al.  Structural aspects of platinum anticancer drug interactions with DNA , 1987 .

[28]  V. Brabec,et al.  DNA modified by platinum derivatives cannot adopt the A-form. , 1986, Biochimica et biophysica acta.

[29]  V. Brabec,et al.  Polarographic studies on the conformation of some platinum complexes: relations to anti-tumour activity. , 1986, Anti-cancer drug design.

[30]  P. Lohman,et al.  Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. , 1985, Biochemistry.

[31]  S. Crooke,et al.  Intermolecular cross-linking of DNA through bifunctional intercalation of an antitumor antibiotic, luzopeptin A (BBM-928A). , 1983, Cancer research.

[32]  E. Paleček,et al.  Interaction of nucleic acids with electrically charged surfaces. II. Conformational changes in double-helical polynucleotides. , 1976, Biophysical chemistry.

[33]  V. Ivanov,et al.  The B to A transition of DNA in solution. , 1974, Journal of molecular biology.

[34]  Sanat K. Dhar,et al.  Metal Ions in Biological Systems , 1973, Advances in Experimental Medicine and Biology.

[35]  E. Paleček,et al.  The influence of salts andpH on polarographic currents produced by denatured DNA , 1970, Biophysik.